SLC2A1 and cancer: Moreover, Akt may inhibit the expression of thioredoxin interacting protein, a negative regulator of the GLUT1 plasma membrane localization, which in turn promotes the plasma membrane distribution of GLUT1 and glucose uptake in cancer cells [188].